Picture for brand Siderlink

Siderlink

GEL FOR THE TREATMENT OF SKIN PIGMENTATIONS OF HEMOSIDERIN

Siderlink is a patented thioglycolic acid-based formulation at 20% (2-MERCAPTOCETIC ACID AT 20%) The product efficacy is due to its capacity to solubilize the hemosiderin and to bond the iron ion using a single active ingredient (2-mercaptoacetic acid).

CATEGORY OF M.D.:
Siderlink is a medical device in class 1

Treatment of cutaneous hyperpigmentations of hemosiderin origins which can often occur during CVI (cronic venous insufficiency), in Phlebology after sclerotherapy, laser, varicectomy. After post-traumatic and surgical therapies or aesthetical treatments (dermo- abrasion, peeling etc). Intravenous infusion administrations.

The product is also useful on epidermal spots of melanic origin.




Do not use the product on skin lesions (abrasions, excorations, burns, phlyctena), after sun exposition in summer time, just after wax depilatory treatments.

The use on the skin is generally well tolerated; but it is very important to test any skin reactivity during the first applications leaving the gel on the treated part for a short application time. Do not use it if there is a skin intolerance. Avoid eyes  and  mucous membrane contact and if it happens wash immediately the site with tap water or with weakly basic solutions such as bicarbonate solution at 5%. Do not ingest the product and keep it away from children.

• SIDERLINK gel (thioglycolic acid at 20%) 15 single use tubes 2 g/each
• DETERLINK Cleansing milk to clean the skin 1 vial of 50 ml
• NEUTROLINK Neutralizing lotion 2 vials of 50 ml/vial (Buffer solution to wash and neutralize the treated site)

VALIDITY: 24 months for unopened package.

SIDERLINK (small tube): after opening use within 30 days.

DETERLINK/NEUTROLINK:  PAO 12 months.

Once open keep the kit in a dry place, carefully close the cup of Siderlink after use to avoid the contact with air (the product is subject to easy oxidation).